The University of Chicago Header Logo

Connection

Thomas Gajewski to Hematologic Neoplasms

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Hematologic Neoplasms.
Thomas Gajewski
Connection Strength
0.166
Hematologic Neoplasms
  1. Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies. J Clin Oncol. 2004 Dec 01; 22(23):4816-22.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.